I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Basyal, Mahesh
17
results:
Search for persons
X
Format
Online (17)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
A Phase I study of Milademetan (DS3032b) in combination wit..:
Senapati, Jayastu
;
Muftuoglu, Muharrem
;
Ishizawa, Jo
...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
2
A phase 1/2 study of azacitidine, venetoclax and pevonedist..:
Short, Nicholas J.
;
Muftuoglu, Muharrem
;
Ong, Faustine
...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
3
Epichaperome inhibition targets TP53-mutant AML and AML ste..:
Carter, Bing Z.
;
Mak, Po Yee
;
Muftuoglu, Muharrem
...
Blood. 142 (2023) 12 - p. 1056-1070 , 2023
Link:
https://doi.org/10.1182/..
?
4
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via..:
Jia, Yannan
;
Zhang, Weiguo
;
Basyal, Mahesh
...
Leukemia. 37 (2023) 6 - p. 1379-1383 , 2023
Link:
https://doi.org/10.1038/..
?
5
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibi..:
Zhang, Weiguo
;
Yu, Guopan
;
Zhang, Hongying
...
Haematologica. 108 (2022) 6 - p. 1500-1514 , 2022
Link:
https://doi.org/10.3324/..
?
6
In-depth analysis of SARS-CoV-2–specific T cells reveals di..:
Li, Li
;
Muftuoglu, Muharrem
;
Liang, Shaoheng
...
JCI Insight. 7 (2022) 7 - p. , 2022
Link:
https://doi.org/10.1172/..
?
7
Poster: AML-284: Emvododstat (PTC299) Targets De Novo Pyrim..:
Piya, Sujan
;
Weetall, Marla
;
Sheedy, Josephine
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S215 , 2021
Link:
https://doi.org/10.1016/..
?
8
AML-284: Emvododstat (PTC299) Targets De Novo Pyrimidine Sy..:
Piya, Sujan
;
Weetall, Marla
;
Sheedy, Josephine
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S300 , 2021
Link:
https://doi.org/10.1016/..
?
9
AML-337: Targeting E-Selectin with GMI-1271 Overcomes Micro..:
Chang, Kyung Hee
;
Zhang, Weiguo
;
Basyal, Mahesh
...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S205 , 2020
Link:
https://doi.org/10.1016/..
?
10
A phase 1/2 study of azacitidine, venetoclax and pevonedist..:
Short, Nicholas J
;
Muftuoglu, Muharrem
;
Ong, Faustine
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329789/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
The multi-kinase inhibitor CG-806 exerts anti-cancer activi..:
Yu, Guopan
;
Zhang, Weiguo
;
Zhang, Hongying
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980215/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via..:
Jia, Yannan
;
Zhang, Weiguo
;
Basyal, Mahesh
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244167/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
In-depth analysis of SARS-CoV-2–specific T cells reveals di..:
Li, Li
;
Muftuoglu, Muharrem
;
Liang, Shaoheng
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057595/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
14
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibi..:
Zhang, Weiguo
;
Yu, Guopan
;
Zhang, Hongying
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230429/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
15
A phase 1/2 study of azacitidine, venetoclax and pevonedist..:
Nicholas J. Short
;
Muharrem Muftuoglu
;
Faustine Ong
...
https://doi.org/10.1186/s13045-023-01476-8. , 2023
Link:
https://doi.org/10.1186/..
1-15
